Virtual Cardiology Care Models: Key Research Findings

New research in virtual cardiology

Two recent studies published in Circulation emphasize the potential of virtual cardiology, telemedicine, digital therapeutics, and remote monitoring for heart disease management. Both studies demonstrate how digital technologies can enhance diagnosis, treatment, and holistic management of cardiovascular conditions. In addition, the studies address how virtual cardiology innovations provide more proactive, preventative, and patient-centered heart health solutions.

Study 1 – Virtual Cardiology Care and Potential Benefits

A new study published in Circulation highlights the potential benefits of virtual-first cardiology care programs. The study examined 230 patients enrolled in a longitudinal virtual cardiology program in partnership with primary care providers. The results demonstrated that this innovative care model led to increases in new diagnoses, improved blood pressure control, more use of guideline-directed medical therapies, and high patient satisfaction.

Virtual Cardiology and Heart Disease Management

One of the most significant findings was that participation in the virtual cardiology program led to meaningful increases in new diagnoses compared to standard primary care alone. The most significant increases occurred in diagnoses of heart failure, atrial fibrillation, and valvular disease. With more diagnoses, patients could begin appropriate treatments sooner, leading to better management of cardiovascular disease.

Improved Blood Pressure Control

Additionally, the study found that 30.8% of patients saw an improvement in blood pressure control during the program. Another 20.6% reached their target blood pressure goal. This demonstrates the value of having specialist oversight and virtual access to cardiology care in improving this critical risk factor for heart disease and stroke.

Uptake in Guideline-Directed Therapies

The use of recommended preventive medications also increased through enrollment in the virtual cardiology program. Aspirin use for primary or secondary prevention rose from 28.3% to 35.7%. Stroke prevention in atrial fibrillation patients increased from 50% to 62.5%. Nearly half of patients were also started on appropriate medications for conditions like heart failure.

High Patient Satisfaction with Virtual Cardiology

Finally, the virtual-first model showed high patient satisfaction. The average Net Promoter Score, which measures the likelihood of a recommendation, was 87. This highlights that patients appreciate the convenience and connected care provided by virtual access to cardiologists.

Overall, this innovative study demonstrates the promise of virtual-first cardiology care in improving diagnosis, treatment, and management of cardiovascular disease when added as a layer to primary care. The results align with a value-based approach to optimizing patient outcomes and satisfaction. More research is needed, but the initial data supports increased use of virtual specialty care models.

Study 2 – Virtual Cardiology and Remote Monitoring for Heart Failure

Similarly, a recent study on remote patient monitoring (RPM) and digital therapeutics for heart failure patients in Quebec’s public healthcare system found positive impacts on hospitalizations, costs, and survival. This study examined a 12-week digital health program for 171 heart failure patients involving mobile app monitoring, automated medication suggestions, and education.

Key Findings: Heart Failure and Remote Patient Monitoring 

The second study highlights the potential of digital health technologies, including remote patient monitoring and early intervention, to improve outcomes for heart failure patients. Key findings show that the RPM intervention group had significantly fewer hospitalizations and emergency room visits than the control group (0.19 vs 0.55 per patient). There was also a positive trend toward improved survival for those receiving remote monitoring and therapeutic interventions (95 days vs 78 days median).

Overall healthcare costs were reduced by 30% in the intervention group ($134,088 vs $174,924). This early study demonstrates that proactive remote monitoring and timely digital therapeutics can reduce hospitalizations and costs while improving survival rates. More comprehensive implementation of virtual care models and early intervention could benefit heart failure patients and healthcare systems.

Key takeaways are reduced hospitalizations and prices and the trend toward better survival. More extensive studies are needed to confirm these promising preliminary findings. However, these early results suggest that virtual care models could provide significant value to patients and healthcare systems.

Understanding the Potential of Virtual Cardiology Care Models

These two studies demonstrate the promise of virtual cardiology care, like telemedicine, remote monitoring, and digital therapeutics. While larger-scale research is necessary, initial evidence indicates digital healthcare tools optimize diagnosis, treatment, hospitalizations, costs, and patient satisfaction. Virtual access appears key for the future of cardiovascular care delivery.

To subscribe to Tenovi’s Weekly Research Newsletter, scroll down and find the subscription link below. If you are part of a chronic care management, telehealth, or RPM software and services company, explore Tenovi RPM solutions. Book your free demo and consultation with us today.

Want to dig deeper? Get our FREE quick start guide to understanding RPM.

Learn how remote patient monitoring works, device and platform features, and how to seamlessly connect with fulfillment and data APIs. 

Download the RPM guide by filling out the form below.